FEC (fluorouracil, epirubicin, cyclophosphamide)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FEC (fluorouracil, epirubicin, cyclophosphamide), covering 2019-03-28 to 2019-03-28. Get the full timeline:
Most recent: Clinical Trial Update: Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast Cancer [Phase 3]